Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use - Appoints Non-Executive Director Joe Ciaffoni as chief executive officer, replacing Mark Crossley. The handover is expected to be after Indivior’s annual general meeting in May. Indivior says Crossley is stepping down ‘by mutual agreement’ and ‘following a distinguished tenure’ as CEO since 2020. Crossley joined the board in December. Most recently, he was CEO of Nasdaq-listed Collegium Pharmaceutical Inc.

Current stock price: 669.00 pence, up 2.8% in London on Thursday

12-month change: down 61%

Copyright 2025 Alliance News Ltd. All Rights Reserved.